Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study.
Gleich GJ, Roufosse F, Chupp G, Faguer S, Walz B, Reiter A, Yancey SW, Bentley JH, Steinfeld J; HES Mepolizumab Study Group. Gleich GJ, et al. Among authors: roufosse f. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4431-4440.e1. doi: 10.1016/j.jaip.2021.07.050. Epub 2021 Aug 10. J Allergy Clin Immunol Pract. 2021. PMID: 34389506 Free article. Clinical Trial.
The hypereosinophilic syndrome revisited.
Roufosse F, Cogan E, Goldman M. Roufosse F, et al. Annu Rev Med. 2003;54:169-84. doi: 10.1146/annurev.med.54.101601.152431. Epub 2001 Dec 3. Annu Rev Med. 2003. PMID: 12525672 Review.
Hypereosinophilic syndromes.
Roufosse FE, Goldman M, Cogan E. Roufosse FE, et al. Orphanet J Rare Dis. 2007 Sep 11;2:37. doi: 10.1186/1750-1172-2-37. Orphanet J Rare Dis. 2007. PMID: 17848188 Free PMC article. Review.
Lymphocytic variant hypereosinophilic syndromes.
Roufosse F, Cogan E, Goldman M. Roufosse F, et al. Immunol Allergy Clin North Am. 2007 Aug;27(3):389-413. doi: 10.1016/j.iac.2007.07.002. Immunol Allergy Clin North Am. 2007. PMID: 17868856 Review.
Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon HU, Schwartz LB, Rosenwasser LJ, Ring J, Griffin EF, Haig AE, Frewer PI, Parkin JM, Gleich GJ; Mepolizumab HES Study Group. Rothenberg ME, et al. Among authors: roufosse fe. N Engl J Med. 2008 Mar 20;358(12):1215-28. doi: 10.1056/NEJMoa070812. Epub 2008 Mar 16. N Engl J Med. 2008. PMID: 18344568 Free article. Clinical Trial.
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.
Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE, Leiferman KM, Nutman TB, Pfab F, Ring J, Rothenberg ME, Roufosse F, Sajous MH, Sheikh J, Simon D, Simon HU, Stein ML, Wardlaw A, Weller PF, Klion AD. Ogbogu PU, et al. Among authors: roufosse f. J Allergy Clin Immunol. 2009 Dec;124(6):1319-25.e3. doi: 10.1016/j.jaci.2009.09.022. J Allergy Clin Immunol. 2009. PMID: 19910029 Free PMC article.
Sustained response to mepolizumab in refractory Churg-Strauss syndrome.
Kahn JE, Grandpeix-Guyodo C, Marroun I, Catherinot E, Mellot F, Roufosse F, Blétry O. Kahn JE, et al. Among authors: roufosse f. J Allergy Clin Immunol. 2010 Jan;125(1):267-70. doi: 10.1016/j.jaci.2009.10.014. J Allergy Clin Immunol. 2010. PMID: 20109753 No abstract available.
Practical approach to the patient with hypereosinophilia.
Roufosse F, Weller PF. Roufosse F, et al. J Allergy Clin Immunol. 2010 Jul;126(1):39-44. doi: 10.1016/j.jaci.2010.04.011. Epub 2010 Jun 9. J Allergy Clin Immunol. 2010. PMID: 20538328 Free PMC article. Review.
85 results